NRIX

News Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout

14d ago

News Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts

14d ago

News Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates

14d ago

News Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights

14d ago

News Nurix Therapeutics (NRIX) Moves 7.7% Higher: Will This Strength Last?

14d ago

Insider trade Sale by Houte Hans Van (Chief Financial Officer)

27d ago

Insider trade Sale by Christine Ring (Chief Legal Officer)

28d ago

Insider trade Sale by Christine Ring (Chief Legal Officer)

31d ago

Insider trade Sale by Gwenn Hansen (Chief Scientific Officer)

32d ago

Insider trade Sale by Houte Hans Van (Chief Financial Officer)

32d ago

Insider trade Sale by Christine Ring (Chief Legal Officer)

32d ago

SEC filing NRIX Reports $540.7M Cash, Launches $50M Buyback, Advances Bexobrutideg Phase 3, Targets 2026 INDs

55d ago

SEC filing NRIX Announces $413.65M ATM Equity Offering, Amends Distribution Agreement, Files S-3 Shelf Registration

87d ago

Insider trade Sale by Christine Ring (Chief Legal Officer)

91d ago

Insider trade Sale by Christine Ring (Chief Legal Officer)

104d ago

Insider trade Sale by Christine Ring

104d ago

Insider trade Sale by Houte Hans Van (Chief Financial Officer)

104d ago

Insider trade Sale by Christine Ring (Chief Legal Officer)

104d ago

Insider trade Sale by Gwenn Hansen (Chief Scientific Officer)

104d ago

News Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff

139d ago

News Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia

153d ago

News Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock

153d ago

News Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

153d ago

Scanner Unusual volume (z=3.2)

160d ago